# MRE-IA in Liver Disease and Neurovascular Imaging

> **NCT03601845** · NA · COMPLETED · sponsor: **Université de Sherbrooke** · enrollment: 59 (actual)

## Conditions studied

- Diffuse and Focal Liver Diseases, Cerebral Function

## Interventions

- **OTHER:** Stimuli
- **OTHER:** No stimuli

## Key facts

- **NCT ID:** NCT03601845
- **Lead sponsor:** Université de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-31
- **Primary completion:** 2019-07-01
- **Final completion:** 2019-07-01
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2020-02-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03601845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03601845, "MRE-IA in Liver Disease and Neurovascular Imaging". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03601845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
